Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
The Journal of Biological Chemistry|April 10, 2008
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylationElisa Greggio, Ibardo Zambrano, Alice Kaganovich, et al.Plos One|September 7, 2012
Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimersLaura Civiero, Renée Vancraenenbroeck, Elisa Belluzzi, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 10, 2015
Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substratePetranka Krumova, Lauran Reyniers, Marc Meyer, et al.Cell Reports|March 11, 2023
Secretion of VGF relies on the interplay between LRRK2 and post-Golgi v-SNAREsFrancesca Filippini, Sébastien Nola, Ahmed Zahraoui, et al.The Biochemical Journal|September 19, 2019
Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patientsBelén Fernández, Antonio Jesús Lara Ordóñez, Elena Fdez, et al.Journal of Neurochemistry|June 21, 2014
Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathwaysLauran Reyniers, Maria Grazia Del Giudice, Laura Civiero, et al.Plos One|June 6, 2017
Role of LRRK2 in the regulation of dopamine receptor traffickingMauro Rassu, Maria Grazia Del Giudice, Simona Sanna, et al.NPJ Parkinson'S Disease|February 7, 2023
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkersJean-Marc Taymans, Eugénie Mutez, William Sibran, et al.Human Molecular Genetics|November 6, 2012
MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 proteinHyun Jin Cho, Guoxiang Liu, Seok Min Jin, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2022
Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's DiseaseIlda Coku, Eugénie Mutez, Sabiha Eddarkaoui, et al.Pageof 7